Aprea Therapeutics, Inc. (APRE) Reports Material Event to SEC

Aprea Therapeutics, Inc. (NASDAQ:APRE) filed a Form 8-K with the Securities and Exchange Commission on January 23, 2026, disclosing a material event.

Aprea Therapeutics, Inc.'s stock currently trades at $0.83 with a market capitalization of $5.8M. The Healthcare company's stock moved following the disclosure.